Skip to main content
Premium Trial:

Request an Annual Quote

Does Scientific Policymaking Really Need Another Acronym?

At Science Progress, University of Sussex Ph.D. student Molly Morgan discusses ways to make science and technology policy debates more open and transparent. A key to successfully doing so is to encourage "broad deliberation," she writes, and suggests applying Multicriteria Mapping to these discussions. Developed by Andrew Stirling and others at the University of Sussex, MCM "is based on principles of deliberation, participatory public engagement, and the integration of both 'quantitative' and 'qualitative' approaches to policy appraisal."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.